Pages that link to "Q83760447"

The following pages link to Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy (Q83760447):

Displaying 20 items.

• The Treatment of IgA Nephropathy (Q27005109) (← links)
• Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity (Q33764566) (← links)
• The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. (Q34105415) (← links)
• Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy (Q34971424) (← links)
• Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease (Q35767979) (← links)
• Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis (Q36279214) (← links)
• Primary glomerulonephritis: A review of important recent discoveries (Q36465902) (← links)
• Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria. (Q37150681) (← links)
• Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy (Q37205233) (← links)
• Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models (Q37223452) (← links)
• Actin-associated Proteins in the Pathogenesis of Podocyte Injury (Q37402598) (← links)
• Effect of Vitamin D and Tacrolimus Combination Therapy on IgA Nephropathy (Q40957294) (← links)
• FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression (Q42683699) (← links)
• Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study. (Q47141820) (← links)
• Knocking down Cabin1 induces glomerular podocyte injury (Q49720843) (← links)
• Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy. (Q54223082) (← links)
• Salvia przewalskii extract of total phenolic acids inhibit TLR4 signaling activation in podocyte injury induced by puromycin aminonucleoside in vitro. (Q55406024) (← links)
• Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: a meta-analysis (Q89038384) (← links)
• Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis (Q90084618) (← links)
• Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome (Q92423020) (← links)